Dorsey Wright & Associates - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 154 filers reported holding WUXI PHARMATECH CAYMAN INC in Q2 2014. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.

Quarter-by-quarter ownership
Dorsey Wright & Associates ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$261,000
+20.8%
6,041
+22.3%
0.14%
+32.7%
Q2 2015$216,000
+71.4%
4,940
+26.2%
0.10%
+593.3%
Q2 2014$126,000
-8.0%
3,914
+1.4%
0.02%
-21.1%
Q1 2014$137,000
+0.7%
3,859
-1.7%
0.02%
-5.0%
Q4 2013$136,0003,9250.02%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q2 2014
NameSharesValueWeighting ↓
PSquared Asset Management AG 171,495$7,410,00032.67%
Newport Asia LLC 714,600$30,877,00012.95%
Coupland Cardiff Asset Management LLP 45,000$1,944,0006.29%
NINE MASTS CAPITAL Ltd 525,985$22,730,0005.83%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 2,694,589$116,433,0005.17%
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC 220,131$9,512,0004.79%
Sensato Investors LLC 549,341$23,737,0004.44%
Grandeur Peak Global Advisors, LLC 396,743$17,143,0003.83%
Taconic Capital Advisors LP 2,150,000$92,902,0003.43%
Central Asset Investments & Management Holdings (HK) Ltd 68,815$2,973,0003.26%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders